Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Sep 29, 2016
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Radius Health, Inc.
| -1.23M |
—
|
—
| -33.33% | 2.46M |
Sep 27
| |||||||
Radius Health, Inc.
| 3.69M |
—
|
—
|
∞
| 3.69M |
Jun 6
| |||||||
Radius Health, Inc.
|
0
|
—
|
—
|
—
|
0
|
Apr 23
| |||||||
Kalobios Pharmaceuticals Inc
| 2.63M |
—
|
—
|
∞
| 2.63M |
Feb 5
| |||||||
Kalobios Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Somaxon Pharmaceuticals, Inc.
| -2.30M |
$0.30 | -$694,068.36 | -64.28% | 1.28M |
Jul 6 - Jul 9
| |||||||
Somaxon Pharmaceuticals, Inc.
| -178.56K |
$0.29 | -$51,781.82 | -4.76% | 3.57M |
Jul 2 - Jul 3
| |||||||
Somaxon Pharmaceuticals, Inc.
| -19.50K |
$0.29 | -$5,655.00 | -0.52% | 3.75M |
Jun 28
| |||||||
Somaxon Pharmaceuticals, Inc.
| -12.00K |
$0.29 | -$3,480.00 | -0.32% | 3.76M |
Jun 19
| |||||||
Somaxon Pharmaceuticals, Inc.
| -1.45K |
$0.29 | -$420.50 | -0.04% | 3.78M |
Jun 15
| |||||||
Somaxon Pharmaceuticals, Inc.
| -37.95K |
$0.29 | -$11,006.95 | -0.99% | 3.78M |
Jun 5 - Jun 6
| |||||||
Somaxon Pharmaceuticals, Inc.
| -811.42K |
$0.30 | -$244,402.53 | -17.52% | 3.82M |
May 22 - May 31
| |||||||
Radius Health, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 14
| |||||||
Radius Health, Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 18
| |||||||
Zalicus Inc.
| -738.81K |
$1.03 | -$760,971.21 | -6.22% | 11.13M |
Oct 27
| |||||||
Zalicus Inc.
| -281.20K |
$1.02 | -$286,824.00 | -2.31% | 11.87M |
Oct 25 - Oct 26
| |||||||
Zalicus Inc.
| -322.10K |
$1.03 | -$331,062.00 | -2.58% | 12.15M |
Oct 21 - Oct 24
| |||||||
Zalicus Inc.
| -459.82K |
$1.03 | -$473,263.34 | -3.55% | 12.48M |
Oct 19 - Oct 20
| |||||||
Zalicus Inc.
| -19.64K |
$1.02 | -$20,036.88 | -0.15% | 12.94M |
Oct 17
| |||||||
Zalicus Inc.
| -44.70K |
$1.02 | -$45,594.00 | -0.34% | 12.96M |
Oct 13 - Oct 14
| |||||||
Zalicus Inc.
| -338.30K |
$40.36 | -$13,654,230.00 | -2.54% | 13M |
Oct 11 - Oct 12
| |||||||
Zalicus Inc.
| -505.20K |
$1.03 | -$522,656.00 | -3.65% | 13.34M |
Oct 7 - Oct 10
| |||||||
Zalicus Inc.
| -380.23K |
$1.02 | -$387,836.64 | -2.67% | 13.84M |
Sep 28 - Oct 6
| |||||||
Zalicus Inc.
| -410.00K |
$1.10 | -$451,100.00 | -2.80% | 14.22M |
Sep 26 - Sep 27
| |||||||
Radius Health, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Enteromedics Inc
| 704.61K |
—
|
—
| +73.01% | 1.67M |
Dec 14
| |||||||
Pharmathene, Inc
| 2.86M |
$2.69 | $7,676,682.23 | +81.91% | 6.35M |
Nov 3
| |||||||
Enteromedics Inc
|
0
|
—
|
—
|
—
|
0
|
Sep 30
| |||||||
Aryx Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Sep 30
| |||||||
Aryx Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Aug 13
| |||||||
Poniard Pharmaceuticals, Inc.
| 72.29K |
—
|
—
|
∞
| 72.29K |
Jun 9
| |||||||
Aryx Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Apr 30
| |||||||
Combinatorx, Inc
| -7.91M |
—
|
—
| -35.10% | 14.63M |
Jan 1
| |||||||
Combinatorx, Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Poniard Pharmaceuticals, Inc.
| -494.96K |
$8.19 | -$4,051,293.70 | -7.22% | 6.36M |
Nov 5 - Nov 9
| |||||||
Pharmathene, Inc
|
0
|
—
|
—
|
—
|
0
|
Jul 28
| |||||||
Somaxon Pharmaceuticals, Inc.
| 1.28M |
$1.05 | $1,340,422.65 | +38.04% | 4.63M |
Jul 8
| |||||||
Poniard Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 24
| |||||||
Aryx Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Apr 30
| |||||||
Enteromedics Inc
| 1.77M |
$1.15 | $2,030,323.85 | +43.86% | 5.79M |
Feb 24
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.